A single, low-dose infusion of ketamine produced no significant long-lasting side effects over 3 months of follow-up in patients with treatment-resistant depression, according to a study published online in the Journal of Affective Disorders.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Approximately 20% of people with major depressive disorder (MDD) experienced high or fluctuating suicidal ideation over 12 weeks of treatment with antidepressants, researchers found in a study published in The Journal of Clinical Psychiatry.
Compared with US adults who have never used electronic cigarettes (e-cigarettes), those who have used e-cigarettes had higher odds of reporting a history of a clinical diagnosis of depression, according to a study of nearly 900,000 people.
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.